Gilead prices remdesivir, the only drug greenlighted to treat Covid

Gilead prices remdesivir, the only drug greenlighted to treat Covid

bizjournals

Published

Remdesivir — the only drug authorized by federal regulators to treat Covid-19 patients during the pandemic — will cost $2,340 to $3,120 for a five-day course, drug developer Gilead Sciences Inc. said Monday. The price set by Foster City-based Gilead (NASDAQ: GILD) comes close to what Wall Street analysts predicted Gilead would charge for the antiviral drug, which won emergency use authorization from the Food and Drug Administration in May but has not yet received a full approval from the regulator. Gilead…

Full Article